Literature DB >> 16464743

Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.

Nicolas Cagnard1, Franck Letourneur, Abdellatif Essabbani, Valérie Devauchelle, Sylvie Mistou, Audrey Rapinat, Charles Decraene, Catherine Fournier, Gilles Chiocchia.   

Abstract

Since cytokines and chemokines are important actors in rheumatoid arthritis (RA), the aim of this study was to compare the gene expression profiles in cultured fibroblast-like synoviocytes (FLS) obtained from patients with either RA, or osteoarthritis (OA), focusing our analysis on genes for cytokines and chemokines, and their respective receptors. Gene expression in cultured FLS (third passage) from eight patients with RA (RA-FLS) were compared with gene expression in cultured FLS from nine patients with OA (OA-FLS) using Affymetrix Human Genome U133 Plus 2.0 Array microarray, allowing analysis of over 54,000 transcripts. Among the 171 genes studied (241 probes), limiting the selection of differentially expressed genes to a significant value (p < 0.05), and a differential ratio of expression > 1.6, only four genes, namely IL-32, CCL2, PF4F1 and GDF10 were found to be differentially expressed. Out of these four genes, only higher expression of CCL2 has been reported previously in RA. The newly described cytokine IL-32 was the most prominently differentially expressed gene in the present study, with higher expression in RA-FLS than in OA-FLS (p < 0.0073). IL-32 might have a previously unidentified pivotal role in RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16464743

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  35 in total

Review 1.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.

Authors:  Jida Choi; Suyoung Bae; Jaewoo Hong; Soyoon Ryoo; Hyunjhung Jhun; Kwangwon Hong; Doyoung Yoon; Siyoung Lee; Erk Her; Wonhyuk Choi; Jeonghwan Kim; Tania Azam; Charles A Dinarello; Soohyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

3.  Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.

Authors:  Yubo Sun; David R Mauerhan; Gary S Firestein; Bryan J Loeffler; Edward N Hanley; Helen E Gruber
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

Review 4.  Role of interleukin-32 in chronic rhinosinusitis.

Authors:  Anjeni Keswani; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-02

5.  Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Ghada Alsaleh; Laetitia Sparsa; Emmanuel Chatelus; Mathieu Ehlinger; Jacques-Eric Gottenberg; Dominique Wachsmann; Jean Sibilia
Journal:  Arthritis Res Ther       Date:  2010-07-08       Impact factor: 5.156

6.  Interleukin-32 induces the differentiation of monocytes into macrophage-like cells.

Authors:  Mihai G Netea; Eli C Lewis; Tania Azam; Leo A B Joosten; Jun Jaekal; Su-Young Bae; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

7.  Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA).

Authors:  Fan Zhang; Jian Sha; Thomas G Wood; Cristi L Galindo; Harold R Garner; Mark F Burkart; Giovanni Suarez; Johanna C Sierra; Stacy L Agar; Johnny W Peterson; Ashok K Chopra
Journal:  Cell Signal       Date:  2008-01-17       Impact factor: 4.315

8.  Interleukin-32 expression in the pancreas.

Authors:  Atsushi Nishida; Akira Andoh; Osamu Inatomi; Yoshihide Fujiyama
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

9.  Interleukin-32 positively regulates radiation-induced vascular inflammation.

Authors:  Hanako Kobayashi; Eugenia M Yazlovitskaya; P Charles Lin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

10.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.